Search

everythinglearnresearchcommunity

for

Search:↓

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

5-ARI therapy may help prevent prostate cancer progression.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Nanoparticle systems make cancer treatment less toxic.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Upadacitinib may cause hair loss.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

The combination therapy was effective and well-tolerated, especially in young patients.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

ATP helps prevent skin damage from vandetanib by reducing stress.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.